Abstract
To assess the efficacy of an acellular pertussis vaccine that has been used in Japan since 1981, 283 patients with pertussis were selected among patients with suspected pertussis seen at hospitals located around the Tokyo Metropolitan area from 1981 to 1983. The survey of secondary cases in household contacts showed that attack rates in children 0 to 6 years of age were 73.1% in unimmunized children, 15.0% in those fully immunized by whole-cell vaccines, and 15.4% in those given acellular vaccines. The efficacy of Japanese acellular pertussis vaccines was 79% and was not different from that of whole cell vaccines.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
